These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21098645)

  • 41. Prediction of the intestinal first-pass metabolism of CYP3A and UGT substrates in humans from in vitro data.
    Nishimuta H; Sato K; Yabuki M; Komuro S
    Drug Metab Pharmacokinet; 2011; 26(6):592-601. PubMed ID: 21878741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunochemical identification of UGT isoforms in human small bowel and in caco-2 cell monolayers.
    Paine MF; Fisher MB
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1053-7. PubMed ID: 10891370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells.
    Sabolovic N; Humbert AC; Radominska-Pandya A; Magdalou J
    Biopharm Drug Dispos; 2006 May; 27(4):181-9. PubMed ID: 16477579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism of ebracteolata compound B studied in vitro with human liver microsomes, HepG2 cells, and recombinant human enzymes.
    Zhang X; Yao Y; Lou Y; Jiang H; Wang X; Chai X; Zeng S
    Drug Metab Dispos; 2010 Dec; 38(12):2157-65. PubMed ID: 20837661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.
    Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J
    Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimization of a UDP-glucuronosyltransferase assay for trout liver S9 fractions: activity enhancement by alamethicin, a pore-forming peptide.
    Ladd MA; Fitzsimmons PN; Nichols JW
    Xenobiotica; 2016 Dec; 46(12):1066-1075. PubMed ID: 26947351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa.
    Czernik PJ; Little JM; Barone GW; Raufman JP; Radominska-Pandya A
    Drug Metab Dispos; 2000 Oct; 28(10):1210-6. PubMed ID: 10997942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.
    Sten T; Finel M; Ask B; Rane A; Ekström L
    Steroids; 2009 Nov; 74(12):971-7. PubMed ID: 19643121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intestinal transport of scutellarein and scutellarin and first-pass metabolism by UDP-glucuronosyltransferase-mediated glucuronidation of scutellarein and hydrolysis of scutellarin.
    Wang Y; Ao H; Qian Z; Zheng Y
    Xenobiotica; 2011 Jul; 41(7):538-48. PubMed ID: 21561321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs.
    Subash S; Ahire D; Patel M; Shaikh S; Singh DK; Deshmukh S; Prasad B
    Pharm Res; 2024 Aug; 41(8):1621-1630. PubMed ID: 39107514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants.
    Benoit-Biancamano MO; Connelly J; Villeneuve L; Caron P; Guillemette C
    Drug Metab Dispos; 2009 Feb; 37(2):322-9. PubMed ID: 18971318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6.
    Soikkeli A; Kurkela M; Hirvonen J; Yliperttula M; Finel M
    Assay Drug Dev Technol; 2011 Oct; 9(5):496-502. PubMed ID: 21438674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
    Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
    Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT.
    Ishii Y; An K; Nishimura Y; Yamada H
    Drug Metab Dispos; 2012 Nov; 40(11):2081-9. PubMed ID: 22851616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase-Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
    Kitaguchi T; Mizota T; Ito M; Ohno K; Kobayashi K; Ogawa I; Qiu S; Iwao T; Hanioka N; Tanaka M; Matsunaga T
    Drug Metab Dispos; 2022 Jan; 50(1):17-23. PubMed ID: 34670778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of UDP-sugars, UDP and Mg
    Walia G; Smith AD; Riches Z; Collier AC; Coughtrie MWH
    Xenobiotica; 2018 Sep; 48(9):882-890. PubMed ID: 28868965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of UDP-glucuronosyltransferase 1A6 isoform in Caco-2 cells stimulated with lipopolysaccharide.
    Panaro MA; Cavallo P; Acquafredda A; Cianciulli A; Calvello R; Mitolo V
    Innate Immun; 2010 Oct; 16(5):302-9. PubMed ID: 19710100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.